| 1 | vitro | 13,670 |
| 2 | vivo | 10,646 |
| 3 | situ | 2,385 |
| 4 | utero | 645 |
| 5 | silico | 360 |
| 6 | vacuo | 16 |
| 7 | bydgoszcz | 7 |
| 8 | as-3 | 6 |
| 9 | situ-generated | 6 |
| 10 | tof-patients | 6 |
| 11 | vitro-derived | 5 |
| 12 | 1994-5 | 4 |
| 13 | antigua | 4 |
| 14 | eretz-israel | 4 |
| 15 | prepubertals | 4 |
| 16 | race-discordant | 4 |
| 17 | sinergia | 4 |
| 18 | vitro-expanded | 4 |
| 19 | yoro | 4 |
| 20 | aguascalientes | 3 |
| 21 | babungo | 3 |
| 22 | baina | 3 |
| 23 | berea | 3 |
| 24 | d=3 | 3 |
| 25 | finnmark | 3 |
| 26 | g25 | 3 |
| 27 | hdlc/tc | 3 |
| 28 | hgci2 | 3 |
| 29 | hospite | 3 |
| 30 | lymphoscintigram | 3 |
| 31 | oculo | 3 |
| 32 | sacco | 3 |
| 33 | teerthanker | 3 |
| 34 | virulence-induced | 3 |
| 35 | vivo-like | 3 |
| 36 | δcata | 3 |
| 37 | 16q23.1 | 2 |
| 38 | 1943-45 | 2 |
| 39 | 1982-1987 | 2 |
| 40 | 3p25.3-p26.1 | 2 |
| 41 | 3t3‑l1 | 2 |
| 42 | adeane | 2 |
| 43 | air-particulate | 2 |
| 44 | b-cell- | 2 |
| 45 | behaviour/skills | 2 |
| 46 | bioconverting | 2 |
| 47 | bioflocculation | 2 |
| 48 | bp102 | 2 |
| 49 | br.3 | 2 |
| 50 | butrin | 2 |
| 51 | ckdsi | 2 |
| 52 | ckdsii | 2 |
| 53 | coprofiltratis | 2 |
| 54 | dedu | 2 |
| 55 | dnase1 | 2 |
| 56 | ems/ims | 2 |
| 57 | england/wales | 2 |
| 58 | filter-top | 2 |
| 59 | first-person-perspective | 2 |
| 60 | fricke | 2 |
| 61 | fry1-6 | 2 |
| 62 | hasan | 2 |
| 63 | hdv-positive | 2 |
| 64 | highness | 2 |
| 65 | hlcat+/ldlr+/+ | 2 |
| 66 | hove | 2 |
| 67 | hyposomatotropism | 2 |
| 68 | its-pcr | 2 |
| 69 | krzyz | 2 |
| 70 | lactobacillus- | 2 |
| 71 | logil-6 | 2 |
| 72 | matola | 2 |
| 73 | mehg- | 2 |
| 74 | melanda | 2 |
| 75 | mimika | 2 |
| 76 | moderate-and-vigorous | 2 |
| 77 | neoparen-2 | 2 |
| 78 | normal-responder | 2 |
| 79 | nsdhl | 2 |
| 80 | o-ed | 2 |
| 81 | omega-3-index | 2 |
| 82 | p53wt | 2 |
| 83 | pbmnc-cultured | 2 |
| 84 | pdc-t | 2 |
| 85 | pdgf-treated | 2 |
| 86 | placebo/vehicle-controlled | 2 |
| 87 | portsmouth | 2 |
| 88 | single-canalled | 2 |
| 89 | sticlo | 2 |
| 90 | very-preterm | 2 |
| 91 | vitro-based | 2 |
| 92 | vitro-fertilized | 2 |
| 93 | vleck-type | 2 |
| 94 | y-direction | 2 |
| 95 | yks-stimulated | 2 |
| 96 | zes- | 2 |
| 97 | δbmh1 | 2 |
| 98 | 'premodern | 1 |
| 99 | +fo | 1 |
| 100 | /pubmed | 1 |
| 101 | 1,3-position | 1 |
| 102 | 1-methyl-4-phenylpyridine/1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced | 1 |
| 103 | 10-microl | 1 |
| 104 | 11,685 | 1 |
| 105 | 12-h-intervals | 1 |
| 106 | 16/5,949 | 1 |
| 107 | 1940-76 | 1 |
| 108 | 1950os | 1 |
| 109 | 1952/53 | 1 |
| 110 | 1959-78 | 1 |
| 111 | 1962-1965 | 1 |
| 112 | 1969-70 | 1 |
| 113 | 1970-1 | 1 |
| 114 | 1981-1993 | 1 |
| 115 | 1984-86 | 1 |
| 116 | 1993-97 | 1 |
| 117 | 1995-5 | 1 |
| 118 | 1995-99 | 1 |
| 119 | 1998-1989 | 1 |
| 120 | 19999 | 1 |
| 121 | 2,065/ | 1 |
| 122 | 2,4-dimethyl-hexane | 1 |
| 123 | 2,968 | 1 |
| 124 | 2/1265 | 1 |
| 125 | 2015-16 | 1 |
| 126 | 21.9±10.6 | 1 |
| 127 | 212,552 | 1 |
| 128 | 21m/z | 1 |
| 129 | 24na | 1 |
| 130 | 28/114 | 1 |
| 131 | 3-haa-treated | 1 |
| 132 | 30.7°c±0.8°c | 1 |
| 133 | 31.9±2.1°c | 1 |
| 134 | 34/116 | 1 |
| 135 | 3d3/2 | 1 |
| 136 | 3dt1w-series | 1 |
| 137 | 4.6-month | 1 |
| 138 | 4/251 | 1 |
| 139 | 49/72 | 1 |
| 140 | 4v- | 1 |
| 141 | 5,6,7 | 1 |
| 142 | 5hpo- | 1 |
| 143 | 5xfe+cad | 1 |
| 144 | 6-,8-,12-24- | 1 |
| 145 | 6-12-year-olds | 1 |
| 146 | 6-month- | 1 |
| 147 | 74/317 | 1 |
| 148 | 7q32.3-q33 | 1 |
| 149 | 9/4,358 | 1 |
| 150 | a=b-axis | 1 |
| 151 | abcg2-positive | 1 |
| 152 | abderahman | 1 |
| 153 | abdomen+pelvis | 1 |
| 154 | abdominal/general | 1 |
| 155 | abo- | 1 |
| 156 | acupuncture/moxibustion-related | 1 |
| 157 | acwy+mmrv | 1 |
| 158 | ah-resistant | 1 |
| 159 | aii- | 1 |
| 160 | akt-mtor-s6k-rps6 | 1 |
| 161 | al2o | 1 |
| 162 | aln- | 1 |
| 163 | ambient- | 1 |
| 164 | amlodipine/losartane | 1 |
| 165 | anti-directional | 1 |
| 166 | anti-hsp27- | 1 |
| 167 | anticipation- | 1 |
| 168 | apixaban- | 1 |
| 169 | appetitive- | 1 |
| 170 | aq- | 1 |
| 171 | ar230 | 1 |
| 172 | arlesheim | 1 |
| 173 | arsenite- | 1 |
| 174 | artemether-lumefantrine- | 1 |
| 175 | ask-1 | 1 |
| 176 | asthma- | 1 |
| 177 | asyntomatic | 1 |
| 178 | au565 | 1 |
| 179 | auditory/salience | 1 |
| 180 | ay2011 | 1 |
| 181 | az-group | 1 |
| 182 | aziridination/intramolecular | 1 |
| 183 | b-conglycinin | 1 |
| 184 | babile | 1 |
| 185 | bachikere | 1 |
| 186 | baf3/tpr-met | 1 |
| 187 | bages | 1 |
| 188 | baku | 1 |
| 189 | baptise | 1 |
| 190 | bc/bl | 1 |
| 191 | beta-amyloid- | 1 |
| 192 | bicellular | 1 |
| 193 | bio-optics | 1 |
| 194 | birnin | 1 |
| 195 | blastemal | 1 |
| 196 | blue-fronted | 1 |
| 197 | bmecs-cm | 1 |
| 198 | bms-790052- | 1 |
| 199 | bone-remodeling | 1 |
| 200 | brownell | 1 |
| 201 | buikwe | 1 |
| 202 | busheher | 1 |
| 203 | bvdv-vaccinated | 1 |
| 204 | c20:1- | 1 |
| 205 | c57bl/j6 | 1 |
| 206 | ca2+-80 | 1 |
| 207 | cabg-assigned | 1 |
| 208 | cahsp70a-silenced | 1 |
| 209 | calcination/carbonation | 1 |
| 210 | calpain-dependent | 1 |
| 211 | campe- | 1 |
| 212 | cancer-screenings | 1 |
| 213 | cans/week | 1 |
| 214 | castile- | 1 |
| 215 | catalonia.the | 1 |
| 216 | catolica | 1 |
| 217 | cd-ismefs | 1 |
| 218 | cd-r | 1 |
| 219 | cd23/ige | 1 |
| 220 | cd90- | 1 |
| 221 | cell-production | 1 |
| 222 | cerebrolysin- | 1 |
| 223 | cescsi | 1 |
| 224 | chania | 1 |
| 225 | channel-adherence | 1 |
| 226 | chemotherapy-pretreated | 1 |
| 227 | chf/stat | 1 |
| 228 | child-bed | 1 |
| 229 | child/adolescence | 1 |
| 230 | chilling-tolerant | 1 |
| 231 | chonca | 1 |
| 232 | chondroblastomas | 1 |
| 233 | chung-ju | 1 |
| 234 | clinicogemodynamic | 1 |
| 235 | cnnm3 | 1 |
| 236 | cochallenge | 1 |
| 237 | colon-targeted | 1 |
| 238 | concerting | 1 |
| 239 | cotonou/benin | 1 |
| 240 | covariate- | 1 |
| 241 | cr-a549 | 1 |
| 242 | crni-steel | 1 |
| 243 | cryobags | 1 |
| 244 | cs12 | 1 |
| 245 | csls | 1 |
| 246 | csréf | 1 |
| 247 | cumulative-dose | 1 |
| 248 | curcumin-enhanced | 1 |
| 249 | cyp2b6cyp3a4gsta1 | 1 |
| 250 | d-gal-sensitized | 1 |
| 251 | dabo | 1 |
| 252 | days14 | 1 |
| 253 | deception-vigilance | 1 |
| 254 | dehloran | 1 |
| 255 | delayed-start-to-treat | 1 |
| 256 | deman-rogosa-sharpe | 1 |
| 257 | dermonecrosis | 1 |
| 258 | derotating | 1 |
| 259 | design.two | 1 |
| 260 | dfm- | 1 |
| 261 | diagnostic-accuracy | 1 |
| 262 | dipydidamole | 1 |
| 263 | discogenic-pain | 1 |
| 264 | dl/dte/dl/dta | 1 |
| 265 | domestics | 1 |
| 266 | donéguébougou | 1 |
| 267 | doripenem- | 1 |
| 268 | dorog | 1 |
| 269 | dose-squared | 1 |
| 270 | doxepin- | 1 |
| 271 | dpp4i-controlled | 1 |
| 272 | dreg | 1 |
| 273 | drug-uptake | 1 |
| 274 | dry-mouth-specific | 1 |
| 275 | dsrna-stimulated | 1 |
| 276 | dstrecipients | 1 |
| 277 | dysthymias | 1 |
| 278 | echinocactus | 1 |
| 279 | ecu-emg | 1 |
| 280 | ed12 | 1 |
| 281 | edincik | 1 |
| 282 | edtx3 | 1 |
| 283 | eg51 | 1 |
| 284 | emcc- | 1 |
| 285 | emcc-enrolled | 1 |
| 286 | emfs-exposed | 1 |
| 287 | enos/akt/vegfr | 1 |
| 288 | enterocoele | 1 |
| 289 | eocp | 1 |
| 290 | ep-2634185 | 1 |
| 291 | eskilstuna | 1 |
| 292 | etten- | 1 |
| 293 | europe-assessment | 1 |
| 294 | excess/deficiency | 1 |
| 295 | excitation-contracting | 1 |
| 296 | f685 | 1 |
| 297 | f725 | 1 |
| 298 | fassif-v2 | 1 |
| 299 | feedstock- | 1 |
| 300 | fibinolysis | 1 |
| 301 | fibrosis/apoptosis | 1 |
| 302 | field-friendly | 1 |
| 303 | field-trapping | 1 |
| 304 | finite-element-analysis | 1 |
| 305 | fixed-treatment | 1 |
| 306 | flair-mris | 1 |
| 307 | fluoroaromatic | 1 |
| 308 | food-anticipatory | 1 |
| 309 | food-wrap | 1 |
| 310 | fortran-77 | 1 |
| 311 | free-to-bound | 1 |
| 312 | frequency-times | 1 |
| 313 | fronto-striato-cerebellar | 1 |
| 314 | function-independent | 1 |
| 315 | g-protein- | 1 |
| 316 | ga3-treated | 1 |
| 317 | galliformes | 1 |
| 318 | gammagraphic | 1 |
| 319 | ganciclovir-sensitive | 1 |
| 320 | gapa/b | 1 |
| 321 | gaparquinto | 1 |
| 322 | gash | 1 |
| 323 | gat-measured | 1 |
| 324 | gata1a- | 1 |
| 325 | genbank™ | 1 |
| 326 | germany-prevalence | 1 |
| 327 | girar | 1 |
| 328 | glucogen | 1 |
| 329 | greek-born | 1 |
| 330 | ground-water | 1 |
| 331 | ha1-cho | 1 |
| 332 | ha1/ha2 | 1 |
| 333 | habitat-limited | 1 |
| 334 | haemotological | 1 |
| 335 | hala | 1 |
| 336 | harem | 1 |
| 337 | hba1c-concentration | 1 |
| 338 | hc-unresponsive | 1 |
| 339 | hca-lnpp | 1 |
| 340 | hcmec | 1 |
| 341 | hdac-2 | 1 |
| 342 | hdac3- | 1 |
| 343 | heamotocytes | 1 |
| 344 | hemodialysis-patients | 1 |
| 345 | hemodynanic | 1 |
| 346 | high-birefringence | 1 |
| 347 | high-fat- | 1 |
| 348 | high-rises | 1 |
| 349 | higher-association | 1 |
| 350 | hipertransaminasemia | 1 |
| 351 | histomer | 1 |
| 352 | hiv/viral | 1 |
| 353 | hmfs- | 1 |
| 354 | hollywood-metro | 1 |
| 355 | hookah-cafes | 1 |
| 356 | horsemanship | 1 |
| 357 | hp-pdt-induced | 1 |
| 358 | hsf1+/+ | 1 |
| 359 | hsp-25 | 1 |
| 360 | huaier-treated | 1 |
| 361 | huntingdon | 1 |
| 362 | hut78 | 1 |
| 363 | hvlt-tested | 1 |
| 364 | hw-treated | 1 |
| 365 | hypercalemic | 1 |
| 366 | hyperinfection | 1 |
| 367 | hyperpigmentaion | 1 |
| 368 | hypnotic-opioid | 1 |
| 369 | hypothalmus | 1 |
| 370 | icatibant- | 1 |
| 371 | imatinib-sensitive | 1 |
| 372 | immune-therapeutic | 1 |
| 373 | immunisation.two | 1 |
| 374 | immuno-defficient | 1 |
| 375 | indium-containing | 1 |
| 376 | interferon-sparing | 1 |
| 377 | intron4 | 1 |
| 378 | irp/ire | 1 |
| 379 | jacep | 1 |
| 380 | jak3- | 1 |
| 381 | jayapura | 1 |
| 382 | jejunal- | 1 |
| 383 | kafue | 1 |
| 384 | kamikawa | 1 |
| 385 | khorshid | 1 |
| 386 | kilte | 1 |
| 387 | kinetochore/centromere | 1 |
| 388 | kitgum | 1 |
| 389 | kolaviron- | 1 |
| 390 | kosova | 1 |
| 391 | kyamlaile | 1 |
| 392 | lab-tek | 1 |
| 393 | lamellarin | 1 |
| 394 | lamotrigine- | 1 |
| 395 | laparosupic | 1 |
| 396 | latio₃/srtio₃ | 1 |
| 397 | lc3-green | 1 |
| 398 | learn-phase | 1 |
| 399 | leaves/grains | 1 |
| 400 | lf-dbp | 1 |
| 401 | life-nourishing | 1 |
| 402 | light-adatped | 1 |
| 403 | limbe | 1 |
| 404 | linseed-and | 1 |
| 405 | lipin-1-haploinsufficent | 1 |
| 406 | liveborns | 1 |
| 407 | llw-3-6- | 1 |
| 408 | lncap-gw | 1 |
| 409 | lorne | 1 |
| 410 | low-cost/noninvasive | 1 |
| 411 | maccs-ii | 1 |
| 412 | magnetite-nanoparticle-mediated | 1 |
| 413 | magnetiturn | 1 |
| 414 | magneto-polarization | 1 |
| 415 | mahak | 1 |
| 416 | maignant | 1 |
| 417 | malate/pyruvate- | 1 |
| 418 | mana | 1 |
| 419 | manovacuometric | 1 |
| 420 | masoprocol- | 1 |
| 421 | mature-b-cell | 1 |
| 422 | medical-based | 1 |
| 423 | mesocestoidids | 1 |
| 424 | methionine-adenosyl-transferase | 1 |
| 425 | methyl-xanthine | 1 |
| 426 | methylpentanoic | 1 |
| 427 | mhb | 1 |
| 428 | microcosmal | 1 |
| 429 | microglia/oligodendrocyte | 1 |
| 430 | micromoles/day | 1 |
| 431 | mid-experiment | 1 |
| 432 | midi-ykl | 1 |
| 433 | mini-hlm-patients | 1 |
| 434 | mistissini | 1 |
| 435 | mlo-y4s | 1 |
| 436 | moderate-plus-vigorous | 1 |
| 437 | molar-69xxy | 1 |
| 438 | monoculture- | 1 |
| 439 | monolayer- | 1 |
| 440 | morgantown | 1 |
| 441 | morlupo | 1 |
| 442 | motiyky | 1 |
| 443 | moundou | 1 |
| 444 | mptp- | 1 |
| 445 | mst- | 1 |
| 446 | muonium-based | 1 |
| 447 | myhc-1 | 1 |
| 448 | n5-stz | 1 |
| 449 | nano-electronics | 1 |
| 450 | nanogramms | 1 |
| 451 | naringenine | 1 |
| 452 | nc- | 1 |
| 453 | negeri | 1 |
| 454 | neonatant | 1 |
| 455 | neuro-psychopharmacolium | 1 |
| 456 | new-caledonia | 1 |
| 457 | news-paper | 1 |
| 458 | nf-κb-competent | 1 |
| 459 | nfc- | 1 |
| 460 | nhe3-s526a | 1 |
| 461 | nikolay | 1 |
| 462 | non-attenuation-corrected | 1 |
| 463 | non-efa | 1 |
| 464 | non-literate | 1 |
| 465 | non-pols | 1 |
| 466 | nonanatomically | 1 |
| 467 | nongenetics | 1 |
| 468 | nonpolar×semipolar | 1 |
| 469 | normogastric | 1 |
| 470 | north-europe | 1 |
| 471 | nucleoside-3'-o- | 1 |
| 472 | obesitas | 1 |
| 473 | obesity-resistant | 1 |
| 474 | ocdsymptoms | 1 |
| 475 | oct-3/4-induced | 1 |
| 476 | octan-1-ol | 1 |
| 477 | oenocytes | 1 |
| 478 | onchidoris | 1 |
| 479 | ophtalmology | 1 |
| 480 | ophthalmic-maxillary | 1 |
| 481 | opiate-maintained | 1 |
| 482 | orakei | 1 |
| 483 | orthopaedy | 1 |
| 484 | osu-a9-related | 1 |
| 485 | othorinolaryngology | 1 |
| 486 | over-diuresis | 1 |
| 487 | over-thirties | 1 |
| 488 | overweigth | 1 |
| 489 | pandalus | 1 |
| 490 | par4-mediated | 1 |
| 491 | paracarcinomatous | 1 |
| 492 | parenthood/pregnancy | 1 |
| 493 | paretic- | 1 |
| 494 | parodontal | 1 |
| 495 | paroxetine-controlled | 1 |
| 496 | partially- | 1 |
| 497 | pbs7.4 | 1 |
| 498 | pc12-wt | 1 |
| 499 | pdt- | 1 |
| 500 | pept1- | 1 |
| 501 | percentages.no | 1 |
| 502 | phadebas | 1 |
| 503 | phase2 | 1 |
| 504 | phases-1 | 1 |
| 505 | photosensitizer-dose | 1 |
| 506 | physician-visits | 1 |
| 507 | phú | 1 |
| 508 | pisciarelli | 1 |
| 509 | placentogenesis | 1 |
| 510 | plaque-freel | 1 |
| 511 | pm-enriched | 1 |
| 512 | pmla | 1 |
| 513 | polyneopteran | 1 |
| 514 | polyox® | 1 |
| 515 | polysyndactyl | 1 |
| 516 | ponta | 1 |
| 517 | portraiture | 1 |
| 518 | post-erosion | 1 |
| 519 | post-monotherapy | 1 |
| 520 | pre-/postdesigned | 1 |
| 521 | pre-dbe | 1 |
| 522 | pre-linnaean | 1 |
| 523 | pre-vas | 1 |
| 524 | primer3web | 1 |
| 525 | probinul-neutro®-treated | 1 |
| 526 | prosencephalon | 1 |
| 527 | proximal-udt | 1 |
| 528 | pst/neoadjuvant | 1 |
| 529 | purses | 1 |
| 530 | pyrrhocoris | 1 |
| 531 | qge031- | 1 |
| 532 | qtl/gene | 1 |
| 533 | ra-synovitis | 1 |
| 534 | radiant-1 | 1 |
| 535 | rajouri | 1 |
| 536 | ral+drv | 1 |
| 537 | rayong | 1 |
| 538 | realgar- | 1 |
| 539 | receptor-activation | 1 |
| 540 | relapse-refractory | 1 |
| 541 | res-con | 1 |
| 542 | rescue- | 1 |
| 543 | responders-relapsers | 1 |
| 544 | rh-apc- | 1 |
| 545 | rhgh/rosiglitazone | 1 |
| 546 | rhizogenesis | 1 |
| 547 | ribbon2 | 1 |
| 548 | rifa- | 1 |
| 549 | rkn-infected | 1 |
| 550 | ros/3-nitrotryosine | 1 |
| 551 | rostov-on-don | 1 |
| 552 | rram | 1 |
| 553 | rs1143627 | 1 |
| 554 | rsp- | 1 |
| 555 | saddar | 1 |
| 556 | safety-assessments | 1 |
| 557 | sairei-to-treated | 1 |
| 558 | saline-adenine-glucose | 1 |
| 559 | sawai | 1 |
| 560 | sdf-1á | 1 |
| 561 | secretin- | 1 |
| 562 | sedigheh | 1 |
| 563 | seer-medicare-based | 1 |
| 564 | setúbal | 1 |
| 565 | si-oapical-al | 1 |
| 566 | side-effects.many | 1 |
| 567 | single-culture | 1 |
| 568 | sinoaortic-denervated | 1 |
| 569 | siracusa | 1 |
| 570 | six-patients | 1 |
| 571 | skin-chamber | 1 |
| 572 | smad3‑ | 1 |
| 573 | social-learning | 1 |
| 574 | sod-specific | 1 |
| 575 | solid- | 1 |
| 576 | spring-sown | 1 |
| 577 | spss.16 | 1 |
| 578 | sr2.94 | 1 |
| 579 | st/louis | 1 |
| 580 | stanchion | 1 |
| 581 | sub-specialisation | 1 |
| 582 | succinivibrionaceae | 1 |
| 583 | sugar-fed | 1 |
| 584 | suni | 1 |
| 585 | superphylum | 1 |
| 586 | supine- | 1 |
| 587 | systola | 1 |
| 588 | tadalafil- | 1 |
| 589 | tangential-fired | 1 |
| 590 | tchm-based | 1 |
| 591 | technocentric | 1 |
| 592 | telemetry- | 1 |
| 593 | tgc- | 1 |
| 594 | thethird | 1 |
| 595 | thin-sliced | 1 |
| 596 | third-strand | 1 |
| 597 | ti3c2o2 | 1 |
| 598 | tick-challenge | 1 |
| 599 | toluene-acetonitrile | 1 |
| 600 | tq- | 1 |
| 601 | trade-books | 1 |
| 602 | trans-sarcolemmal | 1 |
| 603 | tribotest | 1 |
| 604 | triton- | 1 |
| 605 | tvi-e/tvi-a | 1 |
| 606 | two-hybrid-yeast | 1 |
| 607 | ucb-induced | 1 |
| 608 | uchumarca | 1 |
| 609 | uitert | 1 |
| 610 | uml | 1 |
| 611 | unhalable | 1 |
| 612 | uni-* | 1 |
| 613 | unix | 1 |
| 614 | unstimulated- | 1 |
| 615 | urinalysis-verified | 1 |
| 616 | utero-intrapartum | 1 |
| 617 | valleytronics | 1 |
| 618 | vatshala | 1 |
| 619 | vc-to-ethene | 1 |
| 620 | vep- | 1 |
| 621 | vestigators | 1 |
| 622 | virto | 1 |
| 623 | vitro- | 1 |
| 624 | vitro-active | 1 |
| 625 | vivi | 1 |
| 626 | vivo-intestinal | 1 |
| 627 | vivo/control | 1 |
| 628 | vivoanti-cancer | 1 |
| 629 | vladimir | 1 |
| 630 | vldl-ch | 1 |
| 631 | wayu | 1 |
| 632 | wdot- | 1 |
| 633 | wg- | 1 |
| 634 | wnk1/4 | 1 |
| 635 | wt-cftr | 1 |
| 636 | wài | 1 |
| 637 | xanxerê | 1 |
| 638 | xenographic | 1 |
| 639 | yellowthroats | 1 |
| 640 | zangiota | 1 |
| 641 | ~10- | 1 |
| 642 | δcatb | 1 |
| 643 | δedv20 | 1 |
| 644 | ε2/ε3 | 1 |
| 645 | ‘stress | 1 |
| 646 | ≤20- | 1 |
| 1 | 'premodern | 1 |
| 2 | +fo | 1 |
| 3 | /pubmed | 1 |
| 4 | 1,3-position | 1 |
| 5 | 1-methyl-4-phenylpyridine/1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced | 1 |
| 6 | 10-microl | 1 |
| 7 | 11,685 | 1 |
| 8 | 12-h-intervals | 1 |
| 9 | 16/5,949 | 1 |
| 10 | 16q23.1 | 2 |
| 11 | 1940-76 | 1 |
| 12 | 1943-45 | 2 |
| 13 | 1950os | 1 |
| 14 | 1952/53 | 1 |
| 15 | 1959-78 | 1 |
| 16 | 1962-1965 | 1 |
| 17 | 1969-70 | 1 |
| 18 | 1970-1 | 1 |
| 19 | 1981-1993 | 1 |
| 20 | 1982-1987 | 2 |
| 21 | 1984-86 | 1 |
| 22 | 1993-97 | 1 |
| 23 | 1994-5 | 4 |
| 24 | 1995-5 | 1 |
| 25 | 1995-99 | 1 |
| 26 | 1998-1989 | 1 |
| 27 | 19999 | 1 |
| 28 | 2,065/ | 1 |
| 29 | 2,4-dimethyl-hexane | 1 |
| 30 | 2,968 | 1 |
| 31 | 2/1265 | 1 |
| 32 | 2015-16 | 1 |
| 33 | 21.9±10.6 | 1 |
| 34 | 212,552 | 1 |
| 35 | 21m/z | 1 |
| 36 | 24na | 1 |
| 37 | 28/114 | 1 |
| 38 | 3-haa-treated | 1 |
| 39 | 30.7°c±0.8°c | 1 |
| 40 | 31.9±2.1°c | 1 |
| 41 | 34/116 | 1 |
| 42 | 3d3/2 | 1 |
| 43 | 3dt1w-series | 1 |
| 44 | 3p25.3-p26.1 | 2 |
| 45 | 3t3‑l1 | 2 |
| 46 | 4.6-month | 1 |
| 47 | 4/251 | 1 |
| 48 | 49/72 | 1 |
| 49 | 4v- | 1 |
| 50 | 5,6,7 | 1 |
| 51 | 5hpo- | 1 |
| 52 | 5xfe+cad | 1 |
| 53 | 6-,8-,12-24- | 1 |
| 54 | 6-12-year-olds | 1 |
| 55 | 6-month- | 1 |
| 56 | 74/317 | 1 |
| 57 | 7q32.3-q33 | 1 |
| 58 | 9/4,358 | 1 |
| 59 | a=b-axis | 1 |
| 60 | abcg2-positive | 1 |
| 61 | abderahman | 1 |
| 62 | abdomen+pelvis | 1 |
| 63 | abdominal/general | 1 |
| 64 | abo- | 1 |
| 65 | acupuncture/moxibustion-related | 1 |
| 66 | acwy+mmrv | 1 |
| 67 | adeane | 2 |
| 68 | aguascalientes | 3 |
| 69 | ah-resistant | 1 |
| 70 | aii- | 1 |
| 71 | air-particulate | 2 |
| 72 | akt-mtor-s6k-rps6 | 1 |
| 73 | al2o | 1 |
| 74 | aln- | 1 |
| 75 | ambient- | 1 |
| 76 | amlodipine/losartane | 1 |
| 77 | anti-directional | 1 |
| 78 | anti-hsp27- | 1 |
| 79 | anticipation- | 1 |
| 80 | antigua | 4 |
| 81 | apixaban- | 1 |
| 82 | appetitive- | 1 |
| 83 | aq- | 1 |
| 84 | ar230 | 1 |
| 85 | arlesheim | 1 |
| 86 | arsenite- | 1 |
| 87 | artemether-lumefantrine- | 1 |
| 88 | as-3 | 6 |
| 89 | ask-1 | 1 |
| 90 | asthma- | 1 |
| 91 | asyntomatic | 1 |
| 92 | au565 | 1 |
| 93 | auditory/salience | 1 |
| 94 | ay2011 | 1 |
| 95 | az-group | 1 |
| 96 | aziridination/intramolecular | 1 |
| 97 | b-cell- | 2 |
| 98 | b-conglycinin | 1 |
| 99 | babile | 1 |
| 100 | babungo | 3 |
| 101 | bachikere | 1 |
| 102 | baf3/tpr-met | 1 |
| 103 | bages | 1 |
| 104 | baina | 3 |
| 105 | baku | 1 |
| 106 | baptise | 1 |
| 107 | bc/bl | 1 |
| 108 | behaviour/skills | 2 |
| 109 | berea | 3 |
| 110 | beta-amyloid- | 1 |
| 111 | bicellular | 1 |
| 112 | bio-optics | 1 |
| 113 | bioconverting | 2 |
| 114 | bioflocculation | 2 |
| 115 | birnin | 1 |
| 116 | blastemal | 1 |
| 117 | blue-fronted | 1 |
| 118 | bmecs-cm | 1 |
| 119 | bms-790052- | 1 |
| 120 | bone-remodeling | 1 |
| 121 | bp102 | 2 |
| 122 | br.3 | 2 |
| 123 | brownell | 1 |
| 124 | buikwe | 1 |
| 125 | busheher | 1 |
| 126 | butrin | 2 |
| 127 | bvdv-vaccinated | 1 |
| 128 | bydgoszcz | 7 |
| 129 | c20:1- | 1 |
| 130 | c57bl/j6 | 1 |
| 131 | ca2+-80 | 1 |
| 132 | cabg-assigned | 1 |
| 133 | cahsp70a-silenced | 1 |
| 134 | calcination/carbonation | 1 |
| 135 | calpain-dependent | 1 |
| 136 | campe- | 1 |
| 137 | cancer-screenings | 1 |
| 138 | cans/week | 1 |
| 139 | castile- | 1 |
| 140 | catalonia.the | 1 |
| 141 | catolica | 1 |
| 142 | cd-ismefs | 1 |
| 143 | cd-r | 1 |
| 144 | cd23/ige | 1 |
| 145 | cd90- | 1 |
| 146 | cell-production | 1 |
| 147 | cerebrolysin- | 1 |
| 148 | cescsi | 1 |
| 149 | chania | 1 |
| 150 | channel-adherence | 1 |
| 151 | chemotherapy-pretreated | 1 |
| 152 | chf/stat | 1 |
| 153 | child-bed | 1 |
| 154 | child/adolescence | 1 |
| 155 | chilling-tolerant | 1 |
| 156 | chonca | 1 |
| 157 | chondroblastomas | 1 |
| 158 | chung-ju | 1 |
| 159 | ckdsi | 2 |
| 160 | ckdsii | 2 |
| 161 | clinicogemodynamic | 1 |
| 162 | cnnm3 | 1 |
| 163 | cochallenge | 1 |
| 164 | colon-targeted | 1 |
| 165 | concerting | 1 |
| 166 | coprofiltratis | 2 |
| 167 | cotonou/benin | 1 |
| 168 | covariate- | 1 |
| 169 | cr-a549 | 1 |
| 170 | crni-steel | 1 |
| 171 | cryobags | 1 |
| 172 | cs12 | 1 |
| 173 | csls | 1 |
| 174 | csréf | 1 |
| 175 | cumulative-dose | 1 |
| 176 | curcumin-enhanced | 1 |
| 177 | cyp2b6cyp3a4gsta1 | 1 |
| 178 | d-gal-sensitized | 1 |
| 179 | d=3 | 3 |
| 180 | dabo | 1 |
| 181 | days14 | 1 |
| 182 | deception-vigilance | 1 |
| 183 | dedu | 2 |
| 184 | dehloran | 1 |
| 185 | delayed-start-to-treat | 1 |
| 186 | deman-rogosa-sharpe | 1 |
| 187 | dermonecrosis | 1 |
| 188 | derotating | 1 |
| 189 | design.two | 1 |
| 190 | dfm- | 1 |
| 191 | diagnostic-accuracy | 1 |
| 192 | dipydidamole | 1 |
| 193 | discogenic-pain | 1 |
| 194 | dl/dte/dl/dta | 1 |
| 195 | dnase1 | 2 |
| 196 | domestics | 1 |
| 197 | donéguébougou | 1 |
| 198 | doripenem- | 1 |
| 199 | dorog | 1 |
| 200 | dose-squared | 1 |
| 201 | doxepin- | 1 |
| 202 | dpp4i-controlled | 1 |
| 203 | dreg | 1 |
| 204 | drug-uptake | 1 |
| 205 | dry-mouth-specific | 1 |
| 206 | dsrna-stimulated | 1 |
| 207 | dstrecipients | 1 |
| 208 | dysthymias | 1 |
| 209 | echinocactus | 1 |
| 210 | ecu-emg | 1 |
| 211 | ed12 | 1 |
| 212 | edincik | 1 |
| 213 | edtx3 | 1 |
| 214 | eg51 | 1 |
| 215 | emcc- | 1 |
| 216 | emcc-enrolled | 1 |
| 217 | emfs-exposed | 1 |
| 218 | ems/ims | 2 |
| 219 | england/wales | 2 |
| 220 | enos/akt/vegfr | 1 |
| 221 | enterocoele | 1 |
| 222 | eocp | 1 |
| 223 | ep-2634185 | 1 |
| 224 | eretz-israel | 4 |
| 225 | eskilstuna | 1 |
| 226 | etten- | 1 |
| 227 | europe-assessment | 1 |
| 228 | excess/deficiency | 1 |
| 229 | excitation-contracting | 1 |
| 230 | f685 | 1 |
| 231 | f725 | 1 |
| 232 | fassif-v2 | 1 |
| 233 | feedstock- | 1 |
| 234 | fibinolysis | 1 |
| 235 | fibrosis/apoptosis | 1 |
| 236 | field-friendly | 1 |
| 237 | field-trapping | 1 |
| 238 | filter-top | 2 |
| 239 | finite-element-analysis | 1 |
| 240 | finnmark | 3 |
| 241 | first-person-perspective | 2 |
| 242 | fixed-treatment | 1 |
| 243 | flair-mris | 1 |
| 244 | fluoroaromatic | 1 |
| 245 | food-anticipatory | 1 |
| 246 | food-wrap | 1 |
| 247 | fortran-77 | 1 |
| 248 | free-to-bound | 1 |
| 249 | frequency-times | 1 |
| 250 | fricke | 2 |
| 251 | fronto-striato-cerebellar | 1 |
| 252 | fry1-6 | 2 |
| 253 | function-independent | 1 |
| 254 | g-protein- | 1 |
| 255 | g25 | 3 |
| 256 | ga3-treated | 1 |
| 257 | galliformes | 1 |
| 258 | gammagraphic | 1 |
| 259 | ganciclovir-sensitive | 1 |
| 260 | gapa/b | 1 |
| 261 | gaparquinto | 1 |
| 262 | gash | 1 |
| 263 | gat-measured | 1 |
| 264 | gata1a- | 1 |
| 265 | genbank™ | 1 |
| 266 | germany-prevalence | 1 |
| 267 | girar | 1 |
| 268 | glucogen | 1 |
| 269 | greek-born | 1 |
| 270 | ground-water | 1 |
| 271 | ha1-cho | 1 |
| 272 | ha1/ha2 | 1 |
| 273 | habitat-limited | 1 |
| 274 | haemotological | 1 |
| 275 | hala | 1 |
| 276 | harem | 1 |
| 277 | hasan | 2 |
| 278 | hba1c-concentration | 1 |
| 279 | hc-unresponsive | 1 |
| 280 | hca-lnpp | 1 |
| 281 | hcmec | 1 |
| 282 | hdac-2 | 1 |
| 283 | hdac3- | 1 |
| 284 | hdlc/tc | 3 |
| 285 | hdv-positive | 2 |
| 286 | heamotocytes | 1 |
| 287 | hemodialysis-patients | 1 |
| 288 | hemodynanic | 1 |
| 289 | hgci2 | 3 |
| 290 | high-birefringence | 1 |
| 291 | high-fat- | 1 |
| 292 | high-rises | 1 |
| 293 | higher-association | 1 |
| 294 | highness | 2 |
| 295 | hipertransaminasemia | 1 |
| 296 | histomer | 1 |
| 297 | hiv/viral | 1 |
| 298 | hlcat+/ldlr+/+ | 2 |
| 299 | hmfs- | 1 |
| 300 | hollywood-metro | 1 |
| 301 | hookah-cafes | 1 |
| 302 | horsemanship | 1 |
| 303 | hospite | 3 |
| 304 | hove | 2 |
| 305 | hp-pdt-induced | 1 |
| 306 | hsf1+/+ | 1 |
| 307 | hsp-25 | 1 |
| 308 | huaier-treated | 1 |
| 309 | huntingdon | 1 |
| 310 | hut78 | 1 |
| 311 | hvlt-tested | 1 |
| 312 | hw-treated | 1 |
| 313 | hypercalemic | 1 |
| 314 | hyperinfection | 1 |
| 315 | hyperpigmentaion | 1 |
| 316 | hypnotic-opioid | 1 |
| 317 | hyposomatotropism | 2 |
| 318 | hypothalmus | 1 |
| 319 | icatibant- | 1 |
| 320 | imatinib-sensitive | 1 |
| 321 | immune-therapeutic | 1 |
| 322 | immunisation.two | 1 |
| 323 | immuno-defficient | 1 |
| 324 | indium-containing | 1 |
| 325 | interferon-sparing | 1 |
| 326 | intron4 | 1 |
| 327 | irp/ire | 1 |
| 328 | its-pcr | 2 |
| 329 | jacep | 1 |
| 330 | jak3- | 1 |
| 331 | jayapura | 1 |
| 332 | jejunal- | 1 |
| 333 | kafue | 1 |
| 334 | kamikawa | 1 |
| 335 | khorshid | 1 |
| 336 | kilte | 1 |
| 337 | kinetochore/centromere | 1 |
| 338 | kitgum | 1 |
| 339 | kolaviron- | 1 |
| 340 | kosova | 1 |
| 341 | krzyz | 2 |
| 342 | kyamlaile | 1 |
| 343 | lab-tek | 1 |
| 344 | lactobacillus- | 2 |
| 345 | lamellarin | 1 |
| 346 | lamotrigine- | 1 |
| 347 | laparosupic | 1 |
| 348 | latio₃/srtio₃ | 1 |
| 349 | lc3-green | 1 |
| 350 | learn-phase | 1 |
| 351 | leaves/grains | 1 |
| 352 | lf-dbp | 1 |
| 353 | life-nourishing | 1 |
| 354 | light-adatped | 1 |
| 355 | limbe | 1 |
| 356 | linseed-and | 1 |
| 357 | lipin-1-haploinsufficent | 1 |
| 358 | liveborns | 1 |
| 359 | llw-3-6- | 1 |
| 360 | lncap-gw | 1 |
| 361 | logil-6 | 2 |
| 362 | lorne | 1 |
| 363 | low-cost/noninvasive | 1 |
| 364 | lymphoscintigram | 3 |
| 365 | maccs-ii | 1 |
| 366 | magnetite-nanoparticle-mediated | 1 |
| 367 | magnetiturn | 1 |
| 368 | magneto-polarization | 1 |
| 369 | mahak | 1 |
| 370 | maignant | 1 |
| 371 | malate/pyruvate- | 1 |
| 372 | mana | 1 |
| 373 | manovacuometric | 1 |
| 374 | masoprocol- | 1 |
| 375 | matola | 2 |
| 376 | mature-b-cell | 1 |
| 377 | medical-based | 1 |
| 378 | mehg- | 2 |
| 379 | melanda | 2 |
| 380 | mesocestoidids | 1 |
| 381 | methionine-adenosyl-transferase | 1 |
| 382 | methyl-xanthine | 1 |
| 383 | methylpentanoic | 1 |
| 384 | mhb | 1 |
| 385 | microcosmal | 1 |
| 386 | microglia/oligodendrocyte | 1 |
| 387 | micromoles/day | 1 |
| 388 | mid-experiment | 1 |
| 389 | midi-ykl | 1 |
| 390 | mimika | 2 |
| 391 | mini-hlm-patients | 1 |
| 392 | mistissini | 1 |
| 393 | mlo-y4s | 1 |
| 394 | moderate-and-vigorous | 2 |
| 395 | moderate-plus-vigorous | 1 |
| 396 | molar-69xxy | 1 |
| 397 | monoculture- | 1 |
| 398 | monolayer- | 1 |
| 399 | morgantown | 1 |
| 400 | morlupo | 1 |
| 401 | motiyky | 1 |
| 402 | moundou | 1 |
| 403 | mptp- | 1 |
| 404 | mst- | 1 |
| 405 | muonium-based | 1 |
| 406 | myhc-1 | 1 |
| 407 | n5-stz | 1 |
| 408 | nano-electronics | 1 |
| 409 | nanogramms | 1 |
| 410 | naringenine | 1 |
| 411 | nc- | 1 |
| 412 | negeri | 1 |
| 413 | neonatant | 1 |
| 414 | neoparen-2 | 2 |
| 415 | neuro-psychopharmacolium | 1 |
| 416 | new-caledonia | 1 |
| 417 | news-paper | 1 |
| 418 | nf-κb-competent | 1 |
| 419 | nfc- | 1 |
| 420 | nhe3-s526a | 1 |
| 421 | nikolay | 1 |
| 422 | non-attenuation-corrected | 1 |
| 423 | non-efa | 1 |
| 424 | non-literate | 1 |
| 425 | non-pols | 1 |
| 426 | nonanatomically | 1 |
| 427 | nongenetics | 1 |
| 428 | nonpolar×semipolar | 1 |
| 429 | normal-responder | 2 |
| 430 | normogastric | 1 |
| 431 | north-europe | 1 |
| 432 | nsdhl | 2 |
| 433 | nucleoside-3'-o- | 1 |
| 434 | o-ed | 2 |
| 435 | obesitas | 1 |
| 436 | obesity-resistant | 1 |
| 437 | ocdsymptoms | 1 |
| 438 | oct-3/4-induced | 1 |
| 439 | octan-1-ol | 1 |
| 440 | oculo | 3 |
| 441 | oenocytes | 1 |
| 442 | omega-3-index | 2 |
| 443 | onchidoris | 1 |
| 444 | ophtalmology | 1 |
| 445 | ophthalmic-maxillary | 1 |
| 446 | opiate-maintained | 1 |
| 447 | orakei | 1 |
| 448 | orthopaedy | 1 |
| 449 | osu-a9-related | 1 |
| 450 | othorinolaryngology | 1 |
| 451 | over-diuresis | 1 |
| 452 | over-thirties | 1 |
| 453 | overweigth | 1 |
| 454 | p53wt | 2 |
| 455 | pandalus | 1 |
| 456 | par4-mediated | 1 |
| 457 | paracarcinomatous | 1 |
| 458 | parenthood/pregnancy | 1 |
| 459 | paretic- | 1 |
| 460 | parodontal | 1 |
| 461 | paroxetine-controlled | 1 |
| 462 | partially- | 1 |
| 463 | pbmnc-cultured | 2 |
| 464 | pbs7.4 | 1 |
| 465 | pc12-wt | 1 |
| 466 | pdc-t | 2 |
| 467 | pdgf-treated | 2 |
| 468 | pdt- | 1 |
| 469 | pept1- | 1 |
| 470 | percentages.no | 1 |
| 471 | phadebas | 1 |
| 472 | phase2 | 1 |
| 473 | phases-1 | 1 |
| 474 | photosensitizer-dose | 1 |
| 475 | physician-visits | 1 |
| 476 | phú | 1 |
| 477 | pisciarelli | 1 |
| 478 | placebo/vehicle-controlled | 2 |
| 479 | placentogenesis | 1 |
| 480 | plaque-freel | 1 |
| 481 | pm-enriched | 1 |
| 482 | pmla | 1 |
| 483 | polyneopteran | 1 |
| 484 | polyox® | 1 |
| 485 | polysyndactyl | 1 |
| 486 | ponta | 1 |
| 487 | portraiture | 1 |
| 488 | portsmouth | 2 |
| 489 | post-erosion | 1 |
| 490 | post-monotherapy | 1 |
| 491 | pre-/postdesigned | 1 |
| 492 | pre-dbe | 1 |
| 493 | pre-linnaean | 1 |
| 494 | pre-vas | 1 |
| 495 | prepubertals | 4 |
| 496 | primer3web | 1 |
| 497 | probinul-neutro®-treated | 1 |
| 498 | prosencephalon | 1 |
| 499 | proximal-udt | 1 |
| 500 | pst/neoadjuvant | 1 |
| 501 | purses | 1 |
| 502 | pyrrhocoris | 1 |
| 503 | qge031- | 1 |
| 504 | qtl/gene | 1 |
| 505 | ra-synovitis | 1 |
| 506 | race-discordant | 4 |
| 507 | radiant-1 | 1 |
| 508 | rajouri | 1 |
| 509 | ral+drv | 1 |
| 510 | rayong | 1 |
| 511 | realgar- | 1 |
| 512 | receptor-activation | 1 |
| 513 | relapse-refractory | 1 |
| 514 | res-con | 1 |
| 515 | rescue- | 1 |
| 516 | responders-relapsers | 1 |
| 517 | rh-apc- | 1 |
| 518 | rhgh/rosiglitazone | 1 |
| 519 | rhizogenesis | 1 |
| 520 | ribbon2 | 1 |
| 521 | rifa- | 1 |
| 522 | rkn-infected | 1 |
| 523 | ros/3-nitrotryosine | 1 |
| 524 | rostov-on-don | 1 |
| 525 | rram | 1 |
| 526 | rs1143627 | 1 |
| 527 | rsp- | 1 |
| 528 | sacco | 3 |
| 529 | saddar | 1 |
| 530 | safety-assessments | 1 |
| 531 | sairei-to-treated | 1 |
| 532 | saline-adenine-glucose | 1 |
| 533 | sawai | 1 |
| 534 | sdf-1á | 1 |
| 535 | secretin- | 1 |
| 536 | sedigheh | 1 |
| 537 | seer-medicare-based | 1 |
| 538 | setúbal | 1 |
| 539 | si-oapical-al | 1 |
| 540 | side-effects.many | 1 |
| 541 | silico | 360 |
| 542 | sinergia | 4 |
| 543 | single-canalled | 2 |
| 544 | single-culture | 1 |
| 545 | sinoaortic-denervated | 1 |
| 546 | siracusa | 1 |
| 547 | situ | 2,385 |
| 548 | situ-generated | 6 |
| 549 | six-patients | 1 |
| 550 | skin-chamber | 1 |
| 551 | smad3‑ | 1 |
| 552 | social-learning | 1 |
| 553 | sod-specific | 1 |
| 554 | solid- | 1 |
| 555 | spring-sown | 1 |
| 556 | spss.16 | 1 |
| 557 | sr2.94 | 1 |
| 558 | st/louis | 1 |
| 559 | stanchion | 1 |
| 560 | sticlo | 2 |
| 561 | sub-specialisation | 1 |
| 562 | succinivibrionaceae | 1 |
| 563 | sugar-fed | 1 |
| 564 | suni | 1 |
| 565 | superphylum | 1 |
| 566 | supine- | 1 |
| 567 | systola | 1 |
| 568 | tadalafil- | 1 |
| 569 | tangential-fired | 1 |
| 570 | tchm-based | 1 |
| 571 | technocentric | 1 |
| 572 | teerthanker | 3 |
| 573 | telemetry- | 1 |
| 574 | tgc- | 1 |
| 575 | thethird | 1 |
| 576 | thin-sliced | 1 |
| 577 | third-strand | 1 |
| 578 | ti3c2o2 | 1 |
| 579 | tick-challenge | 1 |
| 580 | tof-patients | 6 |
| 581 | toluene-acetonitrile | 1 |
| 582 | tq- | 1 |
| 583 | trade-books | 1 |
| 584 | trans-sarcolemmal | 1 |
| 585 | tribotest | 1 |
| 586 | triton- | 1 |
| 587 | tvi-e/tvi-a | 1 |
| 588 | two-hybrid-yeast | 1 |
| 589 | ucb-induced | 1 |
| 590 | uchumarca | 1 |
| 591 | uitert | 1 |
| 592 | uml | 1 |
| 593 | unhalable | 1 |
| 594 | uni-* | 1 |
| 595 | unix | 1 |
| 596 | unstimulated- | 1 |
| 597 | urinalysis-verified | 1 |
| 598 | utero | 645 |
| 599 | utero-intrapartum | 1 |
| 600 | vacuo | 16 |
| 601 | valleytronics | 1 |
| 602 | vatshala | 1 |
| 603 | vc-to-ethene | 1 |
| 604 | vep- | 1 |
| 605 | very-preterm | 2 |
| 606 | vestigators | 1 |
| 607 | virto | 1 |
| 608 | virulence-induced | 3 |
| 609 | vitro | 13,670 |
| 610 | vitro- | 1 |
| 611 | vitro-active | 1 |
| 612 | vitro-based | 2 |
| 613 | vitro-derived | 5 |
| 614 | vitro-expanded | 4 |
| 615 | vitro-fertilized | 2 |
| 616 | vivi | 1 |
| 617 | vivo | 10,646 |
| 618 | vivo-intestinal | 1 |
| 619 | vivo-like | 3 |
| 620 | vivo/control | 1 |
| 621 | vivoanti-cancer | 1 |
| 622 | vladimir | 1 |
| 623 | vldl-ch | 1 |
| 624 | vleck-type | 2 |
| 625 | wayu | 1 |
| 626 | wdot- | 1 |
| 627 | wg- | 1 |
| 628 | wnk1/4 | 1 |
| 629 | wt-cftr | 1 |
| 630 | wài | 1 |
| 631 | xanxerê | 1 |
| 632 | xenographic | 1 |
| 633 | y-direction | 2 |
| 634 | yellowthroats | 1 |
| 635 | yks-stimulated | 2 |
| 636 | yoro | 4 |
| 637 | zangiota | 1 |
| 638 | zes- | 2 |
| 639 | ~10- | 1 |
| 640 | δbmh1 | 2 |
| 641 | δcata | 3 |
| 642 | δcatb | 1 |
| 643 | δedv20 | 1 |
| 644 | ε2/ε3 | 1 |
| 645 | ‘stress | 1 |
| 646 | ≤20- | 1 |
| 1 | uni-* | 1 |
| 2 | hsf1+/+ | 1 |
| 3 | hlcat+/ldlr+/+ | 2 |
| 4 | ~10- | 1 |
| 5 | ≤20- | 1 |
| 6 | cd90- | 1 |
| 7 | qge031- | 1 |
| 8 | c20:1- | 1 |
| 9 | pept1- | 1 |
| 10 | bms-790052- | 1 |
| 11 | hdac3- | 1 |
| 12 | jak3- | 1 |
| 13 | 6-,8-,12-24- | 1 |
| 14 | llw-3-6- | 1 |
| 15 | anti-hsp27- | 1 |
| 16 | gata1a- | 1 |
| 17 | rifa- | 1 |
| 18 | asthma- | 1 |
| 19 | emcc- | 1 |
| 20 | nfc- | 1 |
| 21 | tgc- | 1 |
| 22 | paretic- | 1 |
| 23 | nc- | 1 |
| 24 | rh-apc- | 1 |
| 25 | unstimulated- | 1 |
| 26 | solid- | 1 |
| 27 | beta-amyloid- | 1 |
| 28 | castile- | 1 |
| 29 | lamotrigine- | 1 |
| 30 | supine- | 1 |
| 31 | artemether-lumefantrine- | 1 |
| 32 | campe- | 1 |
| 33 | monoculture- | 1 |
| 34 | covariate- | 1 |
| 35 | malate/pyruvate- | 1 |
| 36 | arsenite- | 1 |
| 37 | rescue- | 1 |
| 38 | appetitive- | 1 |
| 39 | mehg- | 2 |
| 40 | wg- | 1 |
| 41 | 6-month- | 1 |
| 42 | aii- | 1 |
| 43 | feedstock- | 1 |
| 44 | jejunal- | 1 |
| 45 | tadalafil- | 1 |
| 46 | b-cell- | 2 |
| 47 | masoprocol- | 1 |
| 48 | doripenem- | 1 |
| 49 | dfm- | 1 |
| 50 | apixaban- | 1 |
| 51 | etten- | 1 |
| 52 | g-protein- | 1 |
| 53 | doxepin- | 1 |
| 54 | cerebrolysin- | 1 |
| 55 | secretin- | 1 |
| 56 | aln- | 1 |
| 57 | anticipation- | 1 |
| 58 | kolaviron- | 1 |
| 59 | triton- | 1 |
| 60 | nucleoside-3'-o- | 1 |
| 61 | abo- | 1 |
| 62 | 5hpo- | 1 |
| 63 | vitro- | 1 |
| 64 | vep- | 1 |
| 65 | rsp- | 1 |
| 66 | mptp- | 1 |
| 67 | aq- | 1 |
| 68 | tq- | 1 |
| 69 | realgar- | 1 |
| 70 | monolayer- | 1 |
| 71 | zes- | 2 |
| 72 | hmfs- | 1 |
| 73 | lactobacillus- | 2 |
| 74 | high-fat- | 1 |
| 75 | pdt- | 1 |
| 76 | icatibant- | 1 |
| 77 | ambient- | 1 |
| 78 | wdot- | 1 |
| 79 | mst- | 1 |
| 80 | 4v- | 1 |
| 81 | partially- | 1 |
| 82 | telemetry- | 1 |
| 83 | 2,065/ | 1 |
| 84 | δedv20 | 1 |
| 85 | ar230 | 1 |
| 86 | 1969-70 | 1 |
| 87 | ca2+-80 | 1 |
| 88 | 1970-1 | 1 |
| 89 | myhc-1 | 1 |
| 90 | ask-1 | 1 |
| 91 | phases-1 | 1 |
| 92 | radiant-1 | 1 |
| 93 | 16q23.1 | 2 |
| 94 | 3p25.3-p26.1 | 2 |
| 95 | ay2011 | 1 |
| 96 | 4/251 | 1 |
| 97 | eg51 | 1 |
| 98 | cyp2b6cyp3a4gsta1 | 1 |
| 99 | dnase1 | 2 |
| 100 | δbmh1 | 2 |
| 101 | 3t3‑l1 | 2 |
| 102 | hdac-2 | 1 |
| 103 | neoparen-2 | 2 |
| 104 | 3d3/2 | 1 |
| 105 | bp102 | 2 |
| 106 | ed12 | 1 |
| 107 | cs12 | 1 |
| 108 | 212,552 | 1 |
| 109 | 49/72 | 1 |
| 110 | ha1/ha2 | 1 |
| 111 | phase2 | 1 |
| 112 | hgci2 | 3 |
| 113 | ribbon2 | 1 |
| 114 | ti3c2o2 | 1 |
| 115 | fassif-v2 | 1 |
| 116 | as-3 | 6 |
| 117 | br.3 | 2 |
| 118 | 7q32.3-q33 | 1 |
| 119 | 1952/53 | 1 |
| 120 | 1981-1993 | 1 |
| 121 | d=3 | 3 |
| 122 | cnnm3 | 1 |
| 123 | edtx3 | 1 |
| 124 | ε2/ε3 | 1 |
| 125 | pbs7.4 | 1 |
| 126 | wnk1/4 | 1 |
| 127 | 28/114 | 1 |
| 128 | days14 | 1 |
| 129 | sr2.94 | 1 |
| 130 | intron4 | 1 |
| 131 | 1994-5 | 4 |
| 132 | 1995-5 | 1 |
| 133 | hsp-25 | 1 |
| 134 | f725 | 1 |
| 135 | g25 | 3 |
| 136 | 1943-45 | 2 |
| 137 | 2/1265 | 1 |
| 138 | au565 | 1 |
| 139 | 1962-1965 | 1 |
| 140 | ep-2634185 | 1 |
| 141 | 11,685 | 1 |
| 142 | f685 | 1 |
| 143 | fry1-6 | 2 |
| 144 | logil-6 | 2 |
| 145 | 21.9±10.6 | 1 |
| 146 | 2015-16 | 1 |
| 147 | spss.16 | 1 |
| 148 | 34/116 | 1 |
| 149 | 1940-76 | 1 |
| 150 | 1984-86 | 1 |
| 151 | c57bl/j6 | 1 |
| 152 | akt-mtor-s6k-rps6 | 1 |
| 153 | 5,6,7 | 1 |
| 154 | 74/317 | 1 |
| 155 | rs1143627 | 1 |
| 156 | fortran-77 | 1 |
| 157 | 1982-1987 | 2 |
| 158 | 1993-97 | 1 |
| 159 | 9/4,358 | 1 |
| 160 | 2,968 | 1 |
| 161 | 1959-78 | 1 |
| 162 | hut78 | 1 |
| 163 | cr-a549 | 1 |
| 164 | 16/5,949 | 1 |
| 165 | 1998-1989 | 1 |
| 166 | 1995-99 | 1 |
| 167 | 19999 | 1 |
| 168 | tvi-e/tvi-a | 1 |
| 169 | nhe3-s526a | 1 |
| 170 | catolica | 1 |
| 171 | chonca | 1 |
| 172 | uchumarca | 1 |
| 173 | melanda | 2 |
| 174 | berea | 3 |
| 175 | non-efa | 1 |
| 176 | sinergia | 4 |
| 177 | hipertransaminasemia | 1 |
| 178 | chania | 1 |
| 179 | new-caledonia | 1 |
| 180 | mimika | 2 |
| 181 | hala | 1 |
| 182 | vatshala | 1 |
| 183 | pmla | 1 |
| 184 | matola | 2 |
| 185 | systola | 1 |
| 186 | 24na | 1 |
| 187 | mana | 1 |
| 188 | baina | 3 |
| 189 | eskilstuna | 1 |
| 190 | jayapura | 1 |
| 191 | siracusa | 1 |
| 192 | δcata | 3 |
| 193 | dl/dte/dl/dta | 1 |
| 194 | ponta | 1 |
| 195 | zangiota | 1 |
| 196 | antigua | 4 |
| 197 | kosova | 1 |
| 198 | kamikawa | 1 |
| 199 | gapa/b | 1 |
| 200 | primer3web | 1 |
| 201 | mhb | 1 |
| 202 | δcatb | 1 |
| 203 | hcmec | 1 |
| 204 | sod-specific | 1 |
| 205 | dry-mouth-specific | 1 |
| 206 | gammagraphic | 1 |
| 207 | xenographic | 1 |
| 208 | clinicogemodynamic | 1 |
| 209 | hypercalemic | 1 |
| 210 | hemodynanic | 1 |
| 211 | methylpentanoic | 1 |
| 212 | laparosupic | 1 |
| 213 | manovacuometric | 1 |
| 214 | technocentric | 1 |
| 215 | normogastric | 1 |
| 216 | fluoroaromatic | 1 |
| 217 | asyntomatic | 1 |
| 218 | immune-therapeutic | 1 |
| 219 | hdlc/tc | 3 |
| 220 | 31.9±2.1°c | 1 |
| 221 | 30.7°c±0.8°c | 1 |
| 222 | 5xfe+cad | 1 |
| 223 | o-ed | 2 |
| 224 | child-bed | 1 |
| 225 | thin-sliced | 1 |
| 226 | curcumin-enhanced | 1 |
| 227 | cahsp70a-silenced | 1 |
| 228 | oct-3/4-induced | 1 |
| 229 | ucb-induced | 1 |
| 230 | virulence-induced | 3 |
| 231 | 1-methyl-4-phenylpyridine/1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced | 1 |
| 232 | hp-pdt-induced | 1 |
| 233 | vitro-expanded | 4 |
| 234 | sugar-fed | 1 |
| 235 | pm-enriched | 1 |
| 236 | urinalysis-verified | 1 |
| 237 | single-canalled | 2 |
| 238 | emcc-enrolled | 1 |
| 239 | placebo/vehicle-controlled | 2 |
| 240 | paroxetine-controlled | 1 |
| 241 | dpp4i-controlled | 1 |
| 242 | /pubmed | 1 |
| 243 | pre-/postdesigned | 1 |
| 244 | cabg-assigned | 1 |
| 245 | opiate-maintained | 1 |
| 246 | light-adatped | 1 |
| 247 | dose-squared | 1 |
| 248 | tangential-fired | 1 |
| 249 | gat-measured | 1 |
| 250 | pbmnc-cultured | 2 |
| 251 | seer-medicare-based | 1 |
| 252 | medical-based | 1 |
| 253 | tchm-based | 1 |
| 254 | muonium-based | 1 |
| 255 | vitro-based | 2 |
| 256 | emfs-exposed | 1 |
| 257 | ga3-treated | 1 |
| 258 | 3-haa-treated | 1 |
| 259 | pdgf-treated | 2 |
| 260 | sairei-to-treated | 1 |
| 261 | huaier-treated | 1 |
| 262 | hw-treated | 1 |
| 263 | probinul-neutro®-treated | 1 |
| 264 | chemotherapy-pretreated | 1 |
| 265 | par4-mediated | 1 |
| 266 | magnetite-nanoparticle-mediated | 1 |
| 267 | osu-a9-related | 1 |
| 268 | acupuncture/moxibustion-related | 1 |
| 269 | dsrna-stimulated | 1 |
| 270 | yks-stimulated | 2 |
| 271 | bvdv-vaccinated | 1 |
| 272 | situ-generated | 6 |
| 273 | sinoaortic-denervated | 1 |
| 274 | rkn-infected | 1 |
| 275 | non-attenuation-corrected | 1 |
| 276 | colon-targeted | 1 |
| 277 | habitat-limited | 1 |
| 278 | blue-fronted | 1 |
| 279 | hvlt-tested | 1 |
| 280 | vitro-derived | 5 |
| 281 | vitro-fertilized | 2 |
| 282 | d-gal-sensitized | 1 |
| 283 | khorshid | 1 |
| 284 | hypnotic-opioid | 1 |
| 285 | linseed-and | 1 |
| 286 | third-strand | 1 |
| 287 | free-to-bound | 1 |
| 288 | thethird | 1 |
| 289 | succinivibrionaceae | 1 |
| 290 | pre-dbe | 1 |
| 291 | limbe | 1 |
| 292 | deception-vigilance | 1 |
| 293 | child/adolescence | 1 |
| 294 | high-birefringence | 1 |
| 295 | auditory/salience | 1 |
| 296 | germany-prevalence | 1 |
| 297 | channel-adherence | 1 |
| 298 | cd23/ige | 1 |
| 299 | tick-challenge | 1 |
| 300 | cochallenge | 1 |
| 301 | catalonia.the | 1 |
| 302 | drug-uptake | 1 |
| 303 | fricke | 2 |
| 304 | vivo-like | 3 |
| 305 | unhalable | 1 |
| 306 | enterocoele | 1 |
| 307 | kyamlaile | 1 |
| 308 | babile | 1 |
| 309 | toluene-acetonitrile | 1 |
| 310 | dipydidamole | 1 |
| 311 | adeane | 2 |
| 312 | amlodipine/losartane | 1 |
| 313 | 2,4-dimethyl-hexane | 1 |
| 314 | qtl/gene | 1 |
| 315 | vc-to-ethene | 1 |
| 316 | methyl-xanthine | 1 |
| 317 | naringenine | 1 |
| 318 | ros/3-nitrotryosine | 1 |
| 319 | rhgh/rosiglitazone | 1 |
| 320 | lorne | 1 |
| 321 | north-europe | 1 |
| 322 | deman-rogosa-sharpe | 1 |
| 323 | vleck-type | 2 |
| 324 | bachikere | 1 |
| 325 | kinetochore/centromere | 1 |
| 326 | irp/ire | 1 |
| 327 | portraiture | 1 |
| 328 | single-culture | 1 |
| 329 | learn-phase | 1 |
| 330 | methionine-adenosyl-transferase | 1 |
| 331 | baptise | 1 |
| 332 | saline-adenine-glucose | 1 |
| 333 | cumulative-dose | 1 |
| 334 | photosensitizer-dose | 1 |
| 335 | air-particulate | 2 |
| 336 | non-literate | 1 |
| 337 | hospite | 3 |
| 338 | kilte | 1 |
| 339 | microglia/oligodendrocyte | 1 |
| 340 | kafue | 1 |
| 341 | low-cost/noninvasive | 1 |
| 342 | hc-unresponsive | 1 |
| 343 | vitro-active | 1 |
| 344 | first-person-perspective | 2 |
| 345 | imatinib-sensitive | 1 |
| 346 | ganciclovir-sensitive | 1 |
| 347 | abcg2-positive | 1 |
| 348 | hdv-positive | 2 |
| 349 | hove | 2 |
| 350 | buikwe | 1 |
| 351 | csréf | 1 |
| 352 | dreg | 1 |
| 353 | ecu-emg | 1 |
| 354 | life-nourishing | 1 |
| 355 | bone-remodeling | 1 |
| 356 | indium-containing | 1 |
| 357 | social-learning | 1 |
| 358 | field-trapping | 1 |
| 359 | interferon-sparing | 1 |
| 360 | derotating | 1 |
| 361 | excitation-contracting | 1 |
| 362 | concerting | 1 |
| 363 | bioconverting | 2 |
| 364 | rayong | 1 |
| 365 | dorog | 1 |
| 366 | vldl-ch | 1 |
| 367 | sedigheh | 1 |
| 368 | gash | 1 |
| 369 | overweigth | 1 |
| 370 | 4.6-month | 1 |
| 371 | portsmouth | 2 |
| 372 | sawai | 1 |
| 373 | orakei | 1 |
| 374 | maccs-ii | 1 |
| 375 | ckdsii | 2 |
| 376 | pisciarelli | 1 |
| 377 | mistissini | 1 |
| 378 | suni | 1 |
| 379 | negeri | 1 |
| 380 | rajouri | 1 |
| 381 | cescsi | 1 |
| 382 | ckdsi | 2 |
| 383 | vivi | 1 |
| 384 | wài | 1 |
| 385 | mahak | 1 |
| 386 | cans/week | 1 |
| 387 | lab-tek | 1 |
| 388 | edincik | 1 |
| 389 | finnmark | 3 |
| 390 | si-oapical-al | 1 |
| 391 | setúbal | 1 |
| 392 | haemotological | 1 |
| 393 | blastemal | 1 |
| 394 | trans-sarcolemmal | 1 |
| 395 | microcosmal | 1 |
| 396 | vivo-intestinal | 1 |
| 397 | anti-directional | 1 |
| 398 | abdominal/general | 1 |
| 399 | hiv/viral | 1 |
| 400 | parodontal | 1 |
| 401 | bc/bl | 1 |
| 402 | eretz-israel | 4 |
| 403 | plaque-freel | 1 |
| 404 | crni-steel | 1 |
| 405 | nsdhl | 2 |
| 406 | midi-ykl | 1 |
| 407 | mature-b-cell | 1 |
| 408 | brownell | 1 |
| 409 | uml | 1 |
| 410 | octan-1-ol | 1 |
| 411 | 10-microl | 1 |
| 412 | vivo/control | 1 |
| 413 | polysyndactyl | 1 |
| 414 | lymphoscintigram | 3 |
| 415 | rram | 1 |
| 416 | bmecs-cm | 1 |
| 417 | harem | 1 |
| 418 | arlesheim | 1 |
| 419 | very-preterm | 2 |
| 420 | hyposomatotropism | 2 |
| 421 | kitgum | 1 |
| 422 | neuro-psychopharmacolium | 1 |
| 423 | superphylum | 1 |
| 424 | utero-intrapartum | 1 |
| 425 | pre-linnaean | 1 |
| 426 | abderahman | 1 |
| 427 | polyneopteran | 1 |
| 428 | dehloran | 1 |
| 429 | hasan | 2 |
| 430 | lc3-green | 1 |
| 431 | glucogen | 1 |
| 432 | discogenic-pain | 1 |
| 433 | cotonou/benin | 1 |
| 434 | b-conglycinin | 1 |
| 435 | birnin | 1 |
| 436 | lamellarin | 1 |
| 437 | butrin | 2 |
| 438 | res-con | 1 |
| 439 | rostov-on-don | 1 |
| 440 | huntingdon | 1 |
| 441 | hyperpigmentaion | 1 |
| 442 | stanchion | 1 |
| 443 | post-erosion | 1 |
| 444 | higher-association | 1 |
| 445 | bioflocculation | 2 |
| 446 | calcination/carbonation | 1 |
| 447 | hba1c-concentration | 1 |
| 448 | sub-specialisation | 1 |
| 449 | receptor-activation | 1 |
| 450 | magneto-polarization | 1 |
| 451 | hyperinfection | 1 |
| 452 | y-direction | 2 |
| 453 | cell-production | 1 |
| 454 | 1,3-position | 1 |
| 455 | prosencephalon | 1 |
| 456 | 'premodern | 1 |
| 457 | greek-born | 1 |
| 458 | magnetiturn | 1 |
| 459 | spring-sown | 1 |
| 460 | morgantown | 1 |
| 461 | al2o | 1 |
| 462 | dabo | 1 |
| 463 | sacco | 3 |
| 464 | silico | 360 |
| 465 | +fo | 1 |
| 466 | babungo | 3 |
| 467 | ha1-cho | 1 |
| 468 | sticlo | 2 |
| 469 | oculo | 3 |
| 470 | percentages.no | 1 |
| 471 | morlupo | 1 |
| 472 | utero | 645 |
| 473 | yoro | 4 |
| 474 | hollywood-metro | 1 |
| 475 | vitro | 13,670 |
| 476 | gaparquinto | 1 |
| 477 | virto | 1 |
| 478 | vacuo | 16 |
| 479 | vivo | 10,646 |
| 480 | design.two | 1 |
| 481 | immunisation.two | 1 |
| 482 | food-wrap | 1 |
| 483 | lf-dbp | 1 |
| 484 | eocp | 1 |
| 485 | jacep | 1 |
| 486 | horsemanship | 1 |
| 487 | filter-top | 2 |
| 488 | hca-lnpp | 1 |
| 489 | az-group | 1 |
| 490 | cd-r | 1 |
| 491 | saddar | 1 |
| 492 | fronto-striato-cerebellar | 1 |
| 493 | nonpolar×semipolar | 1 |
| 494 | aziridination/intramolecular | 1 |
| 495 | bicellular | 1 |
| 496 | girar | 1 |
| 497 | its-pcr | 2 |
| 498 | skin-chamber | 1 |
| 499 | vivoanti-cancer | 1 |
| 500 | normal-responder | 2 |
| 501 | busheher | 1 |
| 502 | teerthanker | 3 |
| 503 | histomer | 1 |
| 504 | news-paper | 1 |
| 505 | ground-water | 1 |
| 506 | enos/akt/vegfr | 1 |
| 507 | vladimir | 1 |
| 508 | wt-cftr | 1 |
| 509 | mlo-y4s | 1 |
| 510 | phadebas | 1 |
| 511 | dysthymias | 1 |
| 512 | chondroblastomas | 1 |
| 513 | obesitas | 1 |
| 514 | pre-vas | 1 |
| 515 | nano-electronics | 1 |
| 516 | valleytronics | 1 |
| 517 | nongenetics | 1 |
| 518 | bio-optics | 1 |
| 519 | domestics | 1 |
| 520 | mesocestoidids | 1 |
| 521 | 6-12-year-olds | 1 |
| 522 | hookah-cafes | 1 |
| 523 | bages | 1 |
| 524 | 3dt1w-series | 1 |
| 525 | over-thirties | 1 |
| 526 | england/wales | 2 |
| 527 | frequency-times | 1 |
| 528 | galliformes | 1 |
| 529 | high-rises | 1 |
| 530 | purses | 1 |
| 531 | aguascalientes | 3 |
| 532 | oenocytes | 1 |
| 533 | heamotocytes | 1 |
| 534 | cd-ismefs | 1 |
| 535 | cryobags | 1 |
| 536 | cancer-screenings | 1 |
| 537 | flair-mris | 1 |
| 538 | pyrrhocoris | 1 |
| 539 | onchidoris | 1 |
| 540 | placentogenesis | 1 |
| 541 | rhizogenesis | 1 |
| 542 | over-diuresis | 1 |
| 543 | dermonecrosis | 1 |
| 544 | fibrosis/apoptosis | 1 |
| 545 | finite-element-analysis | 1 |
| 546 | fibinolysis | 1 |
| 547 | coprofiltratis | 2 |
| 548 | ra-synovitis | 1 |
| 549 | st/louis | 1 |
| 550 | abdomen+pelvis | 1 |
| 551 | a=b-axis | 1 |
| 552 | trade-books | 1 |
| 553 | prepubertals | 4 |
| 554 | 12-h-intervals | 1 |
| 555 | behaviour/skills | 2 |
| 556 | non-pols | 1 |
| 557 | csls | 1 |
| 558 | ems/ims | 2 |
| 559 | nanogramms | 1 |
| 560 | ocdsymptoms | 1 |
| 561 | leaves/grains | 1 |
| 562 | liveborns | 1 |
| 563 | 1950os | 1 |
| 564 | responders-relapsers | 1 |
| 565 | vestigators | 1 |
| 566 | highness | 2 |
| 567 | ‘stress | 1 |
| 568 | yellowthroats | 1 |
| 569 | physician-visits | 1 |
| 570 | dstrecipients | 1 |
| 571 | tof-patients | 6 |
| 572 | mini-hlm-patients | 1 |
| 573 | hemodialysis-patients | 1 |
| 574 | six-patients | 1 |
| 575 | safety-assessments | 1 |
| 576 | pandalus | 1 |
| 577 | hypothalmus | 1 |
| 578 | moderate-and-vigorous | 2 |
| 579 | moderate-plus-vigorous | 1 |
| 580 | paracarcinomatous | 1 |
| 581 | echinocactus | 1 |
| 582 | pdc-t | 2 |
| 583 | delayed-start-to-treat | 1 |
| 584 | chf/stat | 1 |
| 585 | proximal-udt | 1 |
| 586 | baf3/tpr-met | 1 |
| 587 | race-discordant | 4 |
| 588 | maignant | 1 |
| 589 | chilling-tolerant | 1 |
| 590 | neonatant | 1 |
| 591 | ah-resistant | 1 |
| 592 | obesity-resistant | 1 |
| 593 | pst/neoadjuvant | 1 |
| 594 | lipin-1-haploinsufficent | 1 |
| 595 | calpain-dependent | 1 |
| 596 | function-independent | 1 |
| 597 | immuno-defficient | 1 |
| 598 | mid-experiment | 1 |
| 599 | europe-assessment | 1 |
| 600 | fixed-treatment | 1 |
| 601 | nf-κb-competent | 1 |
| 602 | uitert | 1 |
| 603 | two-hybrid-yeast | 1 |
| 604 | tribotest | 1 |
| 605 | pc12-wt | 1 |
| 606 | p53wt | 2 |
| 607 | dedu | 2 |
| 608 | chung-ju | 1 |
| 609 | baku | 1 |
| 610 | moundou | 1 |
| 611 | donéguébougou | 1 |
| 612 | situ | 2,385 |
| 613 | wayu | 1 |
| 614 | ral+drv | 1 |
| 615 | acwy+mmrv | 1 |
| 616 | lncap-gw | 1 |
| 617 | omega-3-index | 2 |
| 618 | unix | 1 |
| 619 | micromoles/day | 1 |
| 620 | nikolay | 1 |
| 621 | diagnostic-accuracy | 1 |
| 622 | parenthood/pregnancy | 1 |
| 623 | excess/deficiency | 1 |
| 624 | orthopaedy | 1 |
| 625 | othorinolaryngology | 1 |
| 626 | ophtalmology | 1 |
| 627 | motiyky | 1 |
| 628 | field-friendly | 1 |
| 629 | nonanatomically | 1 |
| 630 | side-effects.many | 1 |
| 631 | post-monotherapy | 1 |
| 632 | ophthalmic-maxillary | 1 |
| 633 | food-anticipatory | 1 |
| 634 | relapse-refractory | 1 |
| 635 | molar-69xxy | 1 |
| 636 | 21m/z | 1 |
| 637 | bydgoszcz | 7 |
| 638 | n5-stz | 1 |
| 639 | krzyz | 2 |
| 640 | latio₃/srtio₃ | 1 |
| 641 | smad3‑ | 1 |
| 642 | sdf-1á | 1 |
| 643 | genbank™ | 1 |
| 644 | xanxerê | 1 |
| 645 | polyox® | 1 |
| 646 | phú | 1 |